[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].

MLA

Neuzillet, Y., et al. “[Observational Survey of the French Urological Association Oncology Committee (CCAFU) Evaluating the Practice of Immediate Postoperative Instillation (IPOP) Using Mitomycin C for Non-Muscle Invasive Bladder Cancer (NMIBC) Treatment].” Progres En Urologie : Journal de l’Association Francaise d’urologie et de La Societe Francaise d’urologie, vol. 26, no. 3, Mar. 2016, pp. 181–90. EBSCOhost, https://doi.org/10.1016/j.purol.2015.12.002.

APA

Neuzillet, Y., Colin, P., Comperat, E., Dubosq, F., Houede, N., Larre, S., Masson-Lecomte, A., Pignot, G., Puech, P., Roumiguie, M., Xylinas, E., Mejean, A., & Roupret, M. (2016). [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]. Progres En Urologie : Journal de l’Association Francaise d’urologie et de La Societe Francaise d’urologie, 26(3), 181–190. https://doi.org/10.1016/j.purol.2015.12.002

Chicago

Neuzillet, Y, P Colin, E Comperat, F Dubosq, N Houede, S Larre, A Masson-Lecomte, et al. 2016. “[Observational Survey of the French Urological Association Oncology Committee (CCAFU) Evaluating the Practice of Immediate Postoperative Instillation (IPOP) Using Mitomycin C for Non-Muscle Invasive Bladder Cancer (NMIBC) Treatment].” Progres En Urologie : Journal de l’Association Francaise d’urologie et de La Societe Francaise d’urologie 26 (3): 181–90. doi:10.1016/j.purol.2015.12.002.